Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women

被引:85
|
作者
Janand-Delenne, B
Chagnaud, C
Raccah, D
Alessi, MC
Juhan-Vague, I
Vague, P
机构
[1] Hop Univ Timone, Serv Nutr Endocrinol Malad Metab, Marseille, France
[2] Hop Univ Timone, Serv Radiol, Marseille, France
[3] Hop Univ Timone, Hematol Lab, Marseille, France
关键词
visceral fat; plasminogen activator inhibitor 1 (PAI-1); weight loss;
D O I
10.1038/sj.ijo.0800585
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To substantiate in a premenopausal population of women, the link between visceral adipose tissue and circulating plasminogen activator inhibitor 1 (PAI-1) levels. DESIGN: Study of correlations between anthropometric parameters and PAI-1 and evaluation of the changes induced by weight loss. SUBJECTS: Forty-two healthy pre-menopausal women (aged 18-51 y, with a wide range of body mass index (BMI, 21-48.8 kg/m(2)). Thirteen women were evaluated after weight loss (6.6 +/- 3.3 kg). MEASUREMENTS: BMI, waist and hip circumferences. Total, subcutaneous and visceral adipose tissue areas at the L3-L4 level by computed tomography. Insulin, cholesterol, triglyceride, HDL cholesterol, PAI-1 activity, PAI-1 antigen and tissue plasminogen activator (tPA) antigen. RESULTS: PAI-1 activity, PAI antigen and tPA antigen were positively correlated with visceral adipose tissue, but not with subcutaneous adipose tissue. This correlation was independent of insulin or triglyceride levels. The amount of visceral adipose tissue explained 28% of the PAI-1 activity variance. Weight loss confirmed this link, PAI-1 diminution being correlated only with visceral adipose tissue loss and not with total fat, insulin or triglyceride decrease. CONCLUSION: This study suggests, like in vitro studies, that visceral fat may be an important contributor to the circulating PAI-1.
引用
收藏
页码:312 / 317
页数:6
相关论文
共 50 条
  • [1] Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women
    B Janand-Delenne
    C Chagnaud
    D Raccah
    MC Alessi
    I Juhan-Vague
    P Vague
    International Journal of Obesity, 1998, 22 : 312 - 317
  • [2] Visceral fat is associated with increased plasminogen activator Inhibitor-1 levels in women.
    JanandDelenne, B
    Chagnaud, C
    Alessi, MC
    JuhanVague, I
    Vague, P
    DIABETOLOGIA, 1997, 40 : 1024 - 1024
  • [3] Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat - Evidence of differences between visceral and subcutaneous deposits
    Bastelica, D
    Morange, P
    Berthet, B
    Borghi, H
    Lacroix, O
    Grino, M
    Juhan-Vague, I
    Alessi, MC
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (01) : 173 - 178
  • [4] Visceral fat-specific regulation of plasminogen activator inhibitor-1 in aged septic mice
    Bruno, Maria E. C.
    Mukherjee, Sujata
    Stromberg, Arnold J.
    Saito, Hiroshi
    Starr, Marlene E.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (01) : 706 - 719
  • [5] Human visceral adipose tissue and the plasminogen activator inhibitor type 1
    Lindeman, J. H. N.
    Pijl, H.
    Toet, K.
    Eilers, P. H. C.
    van Ramshorst, B.
    Buijs, M. M.
    van Bockel, J. H.
    Kooistra, T.
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (11) : 1671 - 1679
  • [6] Human visceral adipose tissue and the plasminogen activator inhibitor type 1
    J H N Lindeman
    H Pijl
    K Toet
    P H C Eilers
    B van Ramshorst
    M M Buijs
    J H van Bockel
    T Kooistra
    International Journal of Obesity, 2007, 31 : 1671 - 1679
  • [7] Epicardial fat thickness: Relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity
    Malavazos, Alexis E.
    Ermetici, Federica
    Cereda, Emanuele
    Coman, Calin
    Locati, Massimo
    Morricone, Lelio
    Corsi, Massimiliano M.
    Ambrosi, Bruno
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (08) : 523 - 530
  • [8] FAT DISTRIBUTION AND PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY IN NONDIABETIC OBESE WOMEN
    VAGUE, P
    JUHANVAGUE, I
    CHABERT, V
    ALESSI, MC
    ATLAN, C
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (09): : 913 - 915
  • [9] Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance
    Zhu, YH
    Carmeliet, P
    Fay, WP
    CIRCULATION, 1999, 99 (23) : 3050 - 3055
  • [10] Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance
    Zhu, YH
    Fay, WP
    CIRCULATION, 1998, 98 (17) : 41 - 41